PharmRev articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Pediatric Cancer Drug Development
Jump to section
- Article
- Abstract
- I. Status of Therapy for Childhood Cancer
- II. Genetics of Childhood Cancer: Dividing a Small Pie
- III. Restrictions in Developing New Agents
- IV. Selection of Agents
- V. Humanized Mice for Immuno-Oncology
- VI. Immuno-Oncology
- VII. Strategies Going Forward
- VIII. Summary
- Authorship Contributions
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters